Program Overview

---

Introduction to Cancer Biomedicine BSc

The Cancer Biomedicine BSc program at UCL is designed to equip students with the skills and knowledge necessary to contribute to the diagnosis, understanding, and treatment of cancer. This degree program is taught by world-renowned researchers at the forefront of cancer research, providing students with a comprehensive understanding of the fast-evolving field of cancer biomedicine.

Program Details

Study Mode and Duration

• The program is offered on a full-time basis.
• The duration of the program is 3 academic years.

Tuition Fees

• UK students: Ł9,535 (2025/26)
• International students: Ł36,500 (2025/26)

Program Start and Application Deadline

• The program starts in September 2025.
• The application deadline is 29 January 2025.

UCAS Course Code

• The UCAS course code for this program is B800.

Entry Requirements

A Levels

• Grades: AAA
• Subjects: Biology and Chemistry are required.
• GCSEs: English Language and Mathematics at grade B or 6.

Contextual Offer

• Grades: ABB
• Subjects: Biology and Chemistry are required at grade B.
• GCSEs: English Language and Mathematics at grade B or 6.

International Baccalaureate (IB) Diploma

• Points: 38
• Subjects: A total of 18 points in three higher-level subjects, including 6 in Biology and Chemistry, with no higher-level score below 5.

Contextual Offer for IB Diploma

• Points: 34
• Subjects: A total of 16 points in three higher-level subjects, including Biology and Chemistry, with no higher-level score below 5.

UK Applicants Qualifications

The program accepts various UK qualifications, including:

• Access to HE Diploma
• BTEC National Diploma
• Cambridge Pre-U Principal Subjects
• Scottish Advanced Highers
• T Levels
• UAL Extended Diploma
• Welsh Baccalaureate

International Applications

Country-specific information for international students can be obtained from the International Students website.

English Language Requirements

• The English language level for this program is Level 3.
• Information about evidence required, acceptable qualifications, and test providers can be found on the English language requirements page.

Course Overview

The Cancer Biomedicine BSc program covers a wide range of topics, including molecular biology, cancer biology and therapeutics, clinical cancer management, and the wider impact of a cancer diagnosis on society. Students will also explore how new cancer treatment strategies are designed and tested in clinical trials and how cancer treatment can be personalized for patients.

Teaching and Learning

• Teaching is delivered through formal lectures, small tutorials, group work, and independent study.
• Year two includes laboratory practicals, and in year three, students undertake a research project and produce a dissertation.
• Lectures are both face-to-face and online, allowing students to review topics at their own pace.

Assessment

Assessments include:

• Exams
• Coursework
• Essays
• Poster presentations
• Critiquing scientific research
• Practical skills assessment (OSPE)
• Online participation
• A written project dissertation as part of the research project in Year 3, along with an oral presentation of the work.

Employability

Cancer Biomedicine graduates are well-equipped to pursue careers in laboratory or clinical research, as well as other professions that require a strong understanding of science and clinical medicine.

Fees and Funding

• Tuition fees for UK and international students are listed above.
• Various funding options are available, including student loans, scholarships, and bursaries.
• Details of UCL's tuition fees, tuition fee policy, and potential increases to fees can be found on the UCL Students website.

Next Steps

Application for admission should be made through UCAS. Applicants are expected to have a firm interest in science, motivation towards further knowledge, critical thinking, and problem-solving skills. The selection process involves the assessment of predicted or achieved academic qualifications, personal statements, and references. There will be no interviews.